Cargando…
L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression
BACKGROUND: Cholangiocarcinoma (CCA) is a malignant biliary tract tumor with an extremely poor prognosis. There is an urgent demand to explore novel therapeutic strategies. L-fucose has been confirmed to participate in anti-inflammation and antitumor activities. However, the effect of L-fucose on th...
Autores principales: | Zhu, Biqiang, Zheng, Jingjing, Hong, Gaichao, Bai, Tao, Qian, Wei, Liu, Jinsong, Hou, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106127/ https://www.ncbi.nlm.nih.gov/pubmed/36728287 http://dx.doi.org/10.1097/CM9.0000000000002368 |
Ejemplares similares
-
Promoting Effect of L-Fucose on the Regeneration of Intestinal Stem Cells through AHR/IL-22 Pathway of Intestinal Lamina Propria Monocytes
por: Tan, Chen, et al.
Publicado: (2022) -
Piezo 1 activation facilitates cholangiocarcinoma metastasis via Hippo/YAP signaling axis
por: Zhu, Biqiang, et al.
Publicado: (2021) -
L-fucose ameliorates the carcinogenic properties of Fusobacterium nucleatum in colorectal cancer
por: Duan, Caihan, et al.
Publicado: (2021) -
Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway
por: Indramanee, Somsiri, et al.
Publicado: (2019) -
Fucose ameliorates the proinflammatory property of Fusobacterium nucleatum in colitis via altering its metabolism
por: Duan, Caihan, et al.
Publicado: (2023)